Literature DB >> 36042053

Timing of antenatal steroid administration for imminent preterm birth: results of a prospective observational study in Germany.

Charlotte Humbeck1, Sinje Jonassen2, Arne Bringewatt2,3, Mascha Pervan2, Achim Rody2, Verena Bossung4,5.   

Abstract

PURPOSE: To evaluate the timing of antenatal steroid administration and associated medical interventions in women with imminent preterm birth.
METHODS: We performed a prospective observational study at a single tertiary center in Germany from September 2018 to August 2019. We included pregnant women who received antenatal steroids for imminent preterm birth and evaluated the interval from administration to birth. 120 women with antenatal steroid application were included into our analysis. Descriptive statistics were performed to analyze factors influencing the timing of antenatal steroids and to evaluate additional medical interventions which women with imminent preterm birth experience.
RESULTS: Of the 120 women included into our study, 35.8% gave birth before 34/0 weeks and 64.2% before 37/0 weeks of gestation. Only 25/120 women (20.8%) delivered within the optimal time window of 1-7 days after antenatal steroid application. 5/120 women (4.2%) only received one dose of antenatal steroids before birth and 3/120 (2.5%) gave birth within 8 to 14 days after antenatal steroids. Most women gave birth more than 14 days after steroid application (72.5%, 87/120). Women with preeclampsia (60%), PPROM (31%), and FGR (30%) had the highest rates of delivery within the optimal time window. Women of all timing groups received additional interventions and medications like antibiotics, tocolytics, or anticoagulation.
CONCLUSION: Our observational data indicate that most pregnant women do not give birth within 7 days after the administration of antenatal steroids. The timing was best for preterm birth due to preeclampsia, PPROM, and FGR. Especially for women with symptoms of preterm labor and bleeding placenta previa, antenatal steroids should be indicated more restrictively to improve neonatal outcome and reduce untimely and unnecessary interventions.
© 2022. The Author(s).

Entities:  

Keywords:  Antenatal steroids; Corticosteroids; Prediction; Preterm birth; Respiratory distress syndrome

Year:  2022        PMID: 36042053     DOI: 10.1007/s00404-022-06724-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.493


  15 in total

1.  Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation.

Authors:  Rintaro Mori; Satoshi Kusuda; Masanori Fujimura
Journal:  J Pediatr       Date:  2011-02-22       Impact factor: 4.406

2.  Association of Short Antenatal Corticosteroid Administration-to-Birth Intervals With Survival and Morbidity Among Very Preterm Infants: Results From the EPICE Cohort.

Authors:  Mikael Norman; Aurelie Piedvache; Klaus Børch; Lene Drasbek Huusom; Anna-Karin Edstedt Bonamy; Elizabeth A Howell; Pierre-Henri Jarreau; Rolf F Maier; Ole Pryds; Liis Toome; Heili Varendi; Tom Weber; Emilija Wilson; Arno Van Heijst; Marina Cuttini; Jan Mazela; Henrique Barros; Patrick Van Reempts; Elizabeth S Draper; Jennifer Zeitlin
Journal:  JAMA Pediatr       Date:  2017-07-01       Impact factor: 16.193

3.  Antenatal corticosteroids: a retrospective cohort study on timing, indications and neonatal outcome.

Authors:  Julia Frändberg; Johan Sandblom; Matteo Bruschettini; Karel Maršál; Karl Kristensen
Journal:  Acta Obstet Gynecol Scand       Date:  2018-02-22       Impact factor: 3.636

4.  [Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth].

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Z Geburtshilfe Neonatol       Date:  2019-10-17       Impact factor: 0.685

5.  National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications.

Authors:  Hannah Blencowe; Simon Cousens; Mikkel Z Oestergaard; Doris Chou; Ann-Beth Moller; Rajesh Narwal; Alma Adler; Claudia Vera Garcia; Sarah Rohde; Lale Say; Joy E Lawn
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

6.  Preterm labour: summary of NICE guidance.

Authors:  Grammati Sarri; Melanie Davies; Maryam Gholitabar; Jane E Norman
Journal:  BMJ       Date:  2015-11-23

Review 7.  Planned caesarean section for women with a twin pregnancy.

Authors:  G Justus Hofmeyr; Jon F Barrett; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2015-12-19

8.  Antenatal corticosteroid therapy (ACT) and size at birth: A population-based analysis using the Finnish Medical Birth Register.

Authors:  Alina Rodriguez; Yingbo Wang; Anohki Ali Khan; Rufus Cartwright; Mika Gissler; Marjo-Riitta Järvelin
Journal:  PLoS Med       Date:  2019-02-26       Impact factor: 11.069

9.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Emma McGoldrick; Fiona Stewart; Roses Parker; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2020-12-25

10.  Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).

Authors:  Sven Kehl; Jörg Dötsch; Kurt Hecher; Dietmar Schlembach; Dagmar Schmitz; Holger Stepan; Ulrich Gembruch
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-11-27       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.